Literature DB >> 29250276

Comparison of the Efficancy and Complication Rates of the Hybrid Maze, Complete Cox-Maze and Catheter Ablation in the Treatment of Atrial Fibrillation.

Ivo K Genev1, Lindsey A Tompkins2, Manorama M Khare3, Farhad Farokhi1.   

Abstract

INTRODUCTION: Atrial fibrillation is the most common cardiac arrhythmia in the United States. It has been associated with a reduction in patient quality of life and more serious complications such as stroke and heart failure. The aim of this study was to compare the efficacy of commonly performed invasive procedures in keeping patients in normal sinus rhythm. METHODS AND
RESULTS: A retrospective chart review was performed on all patients who underwent primary radiofrequency catheter ablation, the complete Cox-maze, or the hybrid maze at OSF Saint Anthony Medical Center between January 2010 and December 2013 (n=140). Immediately post-procedure, arrhythmia recurrence rates did not differ between the groups (p = 0.28). At all follow-up points thereafter, however, differences in procedural efficacy between surgical and catheter therapy remained highly significant (p < 0.001). At 2 years, 20.3% of the catheter ablation patients were in normal sinus rhythm, when compared to 57.9% of hybrid maze and 72.7% the complete Cox-maze groups. A difference in major complication rates was noted (p = 0.04), with the complete Cox-maze having a 17.4%, the hybrid having 22.7%, and the catheter ablation group having 5.6%.
CONCLUSIONS: This study was unable to detect differences in the efficacy rates of the surgical procedures, however they were both superior to catheter ablation. Although the hybrid approach is considered minimally invasive, complication rates were similar to those of the complete Cox-maze. Catheter ablation was the safest procedure, and since evidence of reduced mortality after the use of aggressive rhythm therapy is currently lacking, the results suggest that hybrid surgery for atrial fibrillation should be used after the failure of more conservative measures.

Entities:  

Keywords:  Atrial Fibrillation; Cox Maze; Hybrid Maze; PVI Catheter Ablation

Year:  2017        PMID: 29250276      PMCID: PMC5673392          DOI: 10.4022/jafib.1543

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  21 in total

Review 1.  Catheter ablation for atrial fibrillation.

Authors:  Oussama Wazni; Bruce Wilkoff; Walid Saliba
Journal:  N Engl J Med       Date:  2011-12-15       Impact factor: 91.245

2.  The surgical treatment of atrial fibrillation. IV. Surgical technique.

Authors:  J L Cox
Journal:  J Thorac Cardiovasc Surg       Date:  1991-04       Impact factor: 5.209

Review 3.  Management of atrial fibrillation.

Authors:  Talal Moukabary; Mario D Gonzalez
Journal:  Med Clin North Am       Date:  2015-04-11       Impact factor: 5.456

4.  Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up.

Authors:  Srijoy Mahapatra; Damien J LaPar; Sandeep Kamath; Jason Payne; Kenneth C Bilchick; James M Mangrum; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2011-06       Impact factor: 4.330

Review 5.  Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation.

Authors:  Donna M Polk; Tasneem Z Naqvi
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

6.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

7.  Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial.

Authors:  Lucas V A Boersma; Manuel Castella; Wimjan van Boven; Antonio Berruezo; Alaaddin Yilmaz; Mercedes Nadal; Elena Sandoval; Naiara Calvo; Josep Brugada; Johannes Kelder; Maurits Wijffels; Lluís Mont
Journal:  Circulation       Date:  2011-11-14       Impact factor: 29.690

8.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

9.  HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Europace       Date:  2007-06       Impact factor: 5.214

10.  Minimally invasive surgical treatment of lone atrial fibrillation: early results of hybrid versus standard minimally invasive approach employing radiofrequency sources.

Authors:  Mark La Meir; Sandro Gelsomino; Fabiana Lucà; Laurant Pison; Orlando Parise; Andrea Colella; Gian Franco Gensini; Harry Crijns; Francis Wellens; Jos G Maessen
Journal:  Int J Cardiol       Date:  2012-05-02       Impact factor: 4.164

View more
  6 in total

Review 1.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

2.  Hybrid ablation versus transcatheter ablation for atrial fibrillation: A meta-analysis.

Authors:  Junjie Zhang; Haoliang Sun; Keshuai He; Jiaxi Gu; Rui Zheng; Yongfeng Shao
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

3.  Hybrid convergent ablation versus endocardial catheter ablation for atrial fibrillation: A systematic review and meta-analysis.

Authors:  Mohammed Mhanna; Azizullah Beran; Ahmad Al-Abdouh; Hazem Ayesh; Omar Sajdeya; Omar Srour; Mahmoud Alsaiqali; Odai H Alhasanat; Cameron Burmeister; Abdelrhman M Abumoawad; Paul Chacko
Journal:  J Arrhythm       Date:  2021-11-02

4.  Effect of electrophysiological mapping on non-transmural annulus ablation and atrial fibrillation recurrence prediction after 6 months of Cox-Maze IV procedure.

Authors:  Zhishan Sun; Chengming Fan; Long Song; Hao Zhang; Zenan Jiang; Haoyu Tan; Yaqin Sun; Liming Liu
Journal:  Front Cardiovasc Med       Date:  2022-07-15

Review 5.  Hybrid convergent ablation versus endocardial catheter ablation for atrial fibrillation: a systematic review and meta-analysis of randomised control trials and propensity matched studies.

Authors:  Aditya Eranki; Ashley R Wilson-Smith; Michael L Williams; Campbell D Flynn; Con Manganas
Journal:  J Cardiothorac Surg       Date:  2022-08-13       Impact factor: 1.522

Review 6.  Hybrid Ablation of Atrial Fibrillation: A Contemporary Overview.

Authors:  Massimiliano Marini; Luigi Pannone; Domenico G Della Rocca; Stefano Branzoli; Antonio Bisignani; Sahar Mouram; Alvise Del Monte; Cinzia Monaco; Anaïs Gauthey; Ivan Eltsov; Ingrid Overeinder; Gezim Bala; Alexandre Almorad; Erwin Ströker; Juan Sieira; Pedro Brugada; Mark La Meir; Gian-Battista Chierchia; Carlo De Asmundis; Fabrizio Guarracini
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.